Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: Subanalysis of the phase 3 VISTA study

1. Dimopoulos, M.A.
2. Mateos, M.-V.
3. Richardson, P.G.
4. Schlag, R.
5. Khuageva, N.K.
6. Shpilberg, O.
7. Kropff, M.
8. Spicka, I.
9. Palumbo, A.
10. Wu, K.L.
11. Esseltine, D.-L.
12. Liu, K.
13. Deraedt, W.
14. Cakana, A.
15. Van De Velde, H.
16. San Miguel, J.F.